Rights and permissions
About this article
Cite this article
Temozolomide improves survival, no HRQOL loss in glioblastoma. Pharmacoecon. Outcomes News 495, 9 (2006). https://doi.org/10.2165/00151234-200604950-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200604950-00024